Deflection of Vascular Endothelial Growth Factor Action by SS18-SSX and Composite Vascular Endothelial Growth Factor- And Chemokine (C-X-C Motif) Receptor 4-Targeted Therapy in Synovial Sarcoma
Cancer Science - United States
doi 10.1111/cas.12469
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2014
Authors
Publisher
Wiley